To include your compound in the COVID-19 Resource Center, submit it here.

Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

Microbiome company Nextbiotix S.A.S. (Dijon, France) raised €7 million ($8.1 million) in

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE